3-methyl-1,2,3,4-tetrahydroquinazolin-2-one

CAS No. 24365-65-9

3-methyl-1,2,3,4-tetrahydroquinazolin-2-one( —— )

Catalog No. M28377 CAS No. 24365-65-9

3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
2MG 31 In Stock
5MG 48 In Stock
10MG 71 In Stock
25MG 122 In Stock
50MG 179 In Stock
100MG 267 In Stock
200MG Get Quote In Stock
500MG 663 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
  • Description
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24365-65-9
  • Formula Weight
    162.192
  • Molecular Formula
    C9H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1Cc2ccccc2NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jian Tang, et al. Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum. Phytother Res. 2010 Jun;24(6):821-6.
molnova catalog
related products
  • GSK778

    GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). GSK778 inhibits proliferation, induces a cell cycle arrest and apoptosis.

  • ZL0590

    ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.

  • ZL0580

    ZL0580 induces HIV suppression by inhibiting Tat transactivation and transcription elongation as well as by inducing repressive chromatin structure at the HIV promoter.